Literature DB >> 20601126

Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of Protein Tyrosine Phosphatase-1B.

Pimonrat Ketsawatsomkron1, David W Stepp, David J Fulton, Mario B Marrero.   

Abstract

Insulin resistance is an underlying mechanism of type 2 diabetes and its vascular complications. Recent evidence suggests that crosstalk between angiotensin II (Ang II) and the insulin signaling in vascular smooth muscle cell (VSMC) may contribute to cellular insulin resistance. We hypothesized that Ang II inhibits the anti-mitogenic pathways while enhancing the mitogenic pathways stimulated by insulin via activation of Protein Tyrosine Phosphatase-1B (PTP-1B) in VSMC. We found that Ang II significantly inhibited insulin-induced phosphorylation of tyrosine 608 of IRS-1 and serine 473 of Akt, a downstream member of anti-mitogenic pathway of insulin. In contrast, Ang II increased the serine phosphorylation of IRS-1 which was not affected by the presence of insulin. Activation of p42/p44 MAPK (a mitogenic pathway) induced by insulin was further enhanced by Ang II. Transfection of VSMC with PTP-1B antisense oligonucleotide markedly reduced the effects of Ang II on insulin signaling. Furthermore, an increase in VSMC growth was attenuated by PTP-1B antisense only in the presence of both Ang II and insulin. Finally, we also showed that Ang II-induced activation of PTP-1B in VSMC was PKA/JAK2 dependent. We conclude that Ang II modulates both anti-mitogenic and mitogenic pathways of insulin via the activation of PTP-1B. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20601126      PMCID: PMC4446984          DOI: 10.1016/j.vph.2010.06.001

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  46 in total

1.  Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.

Authors:  Takehide Ogihara; Tomoichiro Asano; Katsuyuki Ando; Yuko Chiba; Hideyuki Sakoda; Motonobu Anai; Nobuhiro Shojima; Hiraku Ono; Yukiko Onishi; Midori Fujishiro; Hideki Katagiri; Yasushi Fukushima; Masatoshi Kikuchi; Noriko Noguchi; Hiroyuki Aburatani; Issei Komuro; Toshiro Fujita
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats.

Authors:  E J Henriksen; S Jacob; T R Kinnick; M K Teachey; M Krekler
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

3.  Differential inducibility of angiotensin II AT2 receptor between SHR and WKY vascular smooth muscle cells.

Authors:  T Ichiki; Y Kambayashi; T Inagami
Journal:  Kidney Int Suppl       Date:  1996-06       Impact factor: 10.545

4.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Authors:  Yong Wu; Jing Ping Ouyang; Ke Wu; Shi Shun Wang; Chong Yuan Wen; Zheng Yuan Xia
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

5.  Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury.

Authors:  M B Wright; R A Seifert; D F Bowen-Pope
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 6.  Protein tyrosine phosphatases: the quest for negative regulators of insulin action.

Authors:  Ernest Asante-Appiah; Brian P Kennedy
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04       Impact factor: 4.310

Review 7.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

Review 8.  Angiotensin II-induced insulin resistance and protein tyrosine phosphatases.

Authors:  Mario B Marrero; David Fulton; David Stepp; David M Stern
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-22       Impact factor: 8.311

9.  High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.

Authors:  Sean Shaw; Xiaodan Wang; Heather Redd; Gwendolyn D Alexander; Carlos M Isales; Mario B Marrero
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

10.  Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.

Authors:  J Navarro-Cid; R Maeso; F Perez-Vizcaino; V Cachofeiro; L M Ruilope; J Tamargo; V Lahera
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

View more
  8 in total

1.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

Review 2.  Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.

Authors:  Ravi Nistala; Adam Whaley-Connell
Journal:  Mol Cell Endocrinol       Date:  2013-02-15       Impact factor: 4.102

3.  Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.

Authors:  H Wang; C Weng; H Chen
Journal:  J Hum Hypertens       Date:  2017-01-19       Impact factor: 3.012

4.  Angiotensin II Inhibits Insulin Receptor Signaling in Adipose Cells.

Authors:  Citlaly Gutierrez-Rodelo; Araceli Arellano-Plancarte; Judith Hernandez-Aranda; Huguet V Landa-Galvan; G Karina Parra-Mercado; Nicole J Moreno-Licona; Karla D Hernandez-Gonzalez; Kevin J Catt; Rafael Villalobos-Molina; J Alberto Olivares-Reyes
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

5.  Phosphoprotein Phosphatase PP2A Regulation of Insulin Receptor Substrate 1 and Insulin Metabolic Signaling.

Authors:  Chirag Mandavia; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-16       Impact factor: 2.041

6.  Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats.

Authors:  Xiao Lu; James S Bean; Ghassan S Kassab; Mark D Rekhter
Journal:  Cardiovasc Diabetol       Date:  2011-06-02       Impact factor: 9.951

Review 7.  Molecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 Diabetes.

Authors:  Sara Casella; Alessandra Bielli; Alessandro Mauriello; Augusto Orlandi
Journal:  Int J Mol Sci       Date:  2015-10-14       Impact factor: 5.923

8.  5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes.

Authors:  Peter M Nelson; Jeremy S Harrod; Kathryn G Lamping
Journal:  Exp Diabetes Res       Date:  2012-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.